PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE + OXALIPLATIN) VERSUS FOLFOX-4 (5-FU/LV + OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

✍ Scribed by G Prolla; LG Borges; E Santos

• Book ID: 118614183
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 99 KB
• Volume: 13
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(11)71988-x